Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) EBT (2016 - 2025)

Avanos Medical (AVNS) has disclosed EBT for 13 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly EBT rose 100.29% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$66.2 million through Dec 2025, up 83.59% year-over-year, with the annual reading at -$66.2 million for FY2025, 83.59% up from the prior year.
  • EBT hit $1.2 million in Q4 2025 for Avanos Medical, up from -$1.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $14.3 million in Q4 2022 to a low of -$420.5 million in Q4 2024.
  • Historically, EBT has averaged -$24.0 million across 5 years, with a median of $1.3 million in 2024.
  • Biggest five-year swings in EBT: crashed 4824.72% in 2024 and later skyrocketed 546.67% in 2025.
  • Year by year, EBT stood at -$23.1 million in 2021, then skyrocketed by 161.9% to $14.3 million in 2022, then crashed by 37.76% to $8.9 million in 2023, then plummeted by 4824.72% to -$420.5 million in 2024, then soared by 100.29% to $1.2 million in 2025.
  • Business Quant data shows EBT for AVNS at $1.2 million in Q4 2025, -$1.2 million in Q3 2025, and -$75.9 million in Q2 2025.